Truist Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.48M | Buy |
32,751
+148
| +0.5% | +$15.7K | 0.01% | 1023 |
|
|
2025
Q1 | $4.05M | Buy |
32,603
+4,054
| +14% | +$503K | 0.01% | 911 |
|
|
2024
Q4 | $3.52M | Buy |
28,549
+4,723
| +20% | +$582K | 0.01% | 975 |
|
|
2024
Q3 | $2.65M | Sell |
23,826
-10,496
| -31% | -$1.17M | ﹤0.01% | 1104 |
|
|
2024
Q2 | $3.66M | Sell |
34,322
-4,577
| -12% | -$489K | 0.01% | 993 |
|
|
2024
Q1 | $4.68M | Sell |
38,899
-507
| -1% | -$61.1K | 0.01% | 898 |
|
|
2023
Q4 | $4.85M | Sell |
39,406
-2,177
| -5% | -$268K | 0.01% | 872 |
|
|
2023
Q3 | $5.38M | Buy |
41,583
+11,168
| +37% | +$1.45M | 0.01% | 812 |
|
|
2023
Q2 | $3.77M | Sell |
30,415
-3,509
| -10% | -$435K | 0.01% | 952 |
|
|
2023
Q1 | $4.96M | Sell |
33,924
-2,336
| -6% | -$342K | 0.01% | 827 |
|
|
2022
Q4 | $5.78M | Buy |
36,260
+2,250
| +7% | +$358K | 0.01% | 770 |
|
|
2022
Q3 | $4.53M | Buy |
34,010
+4,908
| +17% | +$654K | 0.01% | 830 |
|
|
2022
Q2 | $4.54M | Sell |
29,102
-7,017
| -19% | -$1.09M | 0.01% | 837 |
|
|
2022
Q1 | $5.62M | Sell |
36,119
-14,596
| -29% | -$2.27M | 0.01% | 841 |
|
|
2021
Q4 | $6.46M | Buy |
50,715
+8,181
| +19% | +$1.04M | 0.01% | 791 |
|
|
2021
Q3 | $5.54M | Buy |
42,534
+3,657
| +9% | +$476K | 0.01% | 838 |
|
|
2021
Q2 | $6.91M | Buy |
38,877
+194
| +0.5% | +$34.5K | 0.01% | 757 |
|
|
2021
Q1 | $6.36M | Sell |
38,683
-5,907
| -13% | -$971K | 0.01% | 754 |
|
|
2020
Q4 | $7.36M | Buy |
44,590
+5,486
| +14% | +$905K | 0.01% | 689 |
|
|
2020
Q3 | $5.58M | Buy |
39,104
+1,418
| +4% | +$202K | 0.01% | 720 |
|
|
2020
Q2 | $4.16M | Buy |
37,686
+5,688
| +18% | +$628K | 0.01% | 765 |
|
|
2020
Q1 | $3.19M | Sell |
31,998
-20,688
| -39% | -$2.06M | 0.01% | 799 |
|
|
2019
Q4 | $7.87M | Buy |
+52,686
| New | +$7.87M | 0.02% | 629 |
|
|
2014
Q3 | – | Sell |
-1,377
| Closed | -$202K | – | 777 |
|
|
2014
Q2 | $202K | Buy |
+1,377
| New | +$202K | 0.01% | 759 |
|